FDA delays meeting on Pfizer's COVID-19 vaccine for children under 5 to review more data
FDA,Coronavirus Vaccine,Family And Marriage,Public Health
From the Left
AllSides Media Bias Rating: Lean Left
The U.S. Food and Drug Administration has delayed a meeting about a COVID-19 vaccine for children younger than 5 that was originally scheduled to take place next week, raising questions about when they'll be able to get vaccinated against the deadly virus. The FDA said it wants to see more data from Pfizer before proceeding.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
US Loses Measles Elimination Status After 26 Years
November 17th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
Recommended Reading
Do Phones Belong in Class?: Understanding the Phone-Free Schools Debate
The Alliance for Civic Engagement
November 20th, 2026